Coronavirus: Australia to manufacture COVID-19 vaccine, free to citizens

A medical personnel holds a swab while administering a test for the coronavirus disease (COVID-19) at a pop-up testing centre, as the state of New South Wales grapples with an outbreak of new cases, in Sydney, Australia. (Reuters)

Australia has secured access to a “promising” potential coronavirus vaccine, the prime minister announced Tuesday, saying the country would manufacture it and offer free doses to the entire population.

Prime Minister Scott Morrison said Australia had reached a deal with Swedish-British pharmaceutical company AstraZeneca to receive the COVID-19 vaccine it is developing with Oxford University.

“The Oxford vaccine is one of the most advanced and promising in the world, and under this deal we have secured early access for every Australian,” he said.

“If this vaccine proves successful we will manufacture and supply vaccines straight away under our own steam and make it free for 25 million Australians.”

The Oxford vaccine is one of five globally in Phase 3 efficacy trials, and researchers hope to have results by the end of the year.

Britain’s William, Duke of Cambridge, talks to a patient participating in the COVID-19 vaccine trial at the Oxford Vaccine Group’s facility at the Churchill Hospital in Oxford, Britain, June 24, 2020. (Reuters)

Britain’s William, Duke of Cambridge, talks to a patient participating in the COVID-19 vaccine trial at the Oxford Vaccine Group’s facility at the Churchill Hospital in Oxford, Britain, June 24, 2020. (Reuters)

It is the first such deal for Australia, and Morrison said his government was also in talks with “many parties around the world” over other potential vaccines as well as supporting local scientists in their efforts.

The country is yet to reach a final agreement with AstraZeneca on the cost of the vaccine and a local manufacturer has not been locked in.

However, Australia has signed an Aus$25 million ($18 million) agreement with American medical technology company Becton Dickinson to buy 100 million needles and syringes to administer the doses.

Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been pre-ordered around the world.

Five vaccines -- three Western and two Chinese -- are in Phase 3 efficacy trials involving thousands of people, including the Oxford vaccine.

It hopes to have results by the end of the year.

The company has also signed agreements to provide doses to the US, Europe and Brazil.

Another deal struck by Gavi, the Vaccine Alliance, would see India manufacture the Oxford vaccine for distribution in 57 low- and middle-income countries.

First shipments of a COVID-19 vaccine created by Western laboratories have often been snapped up by the US.

Morrison said Australia remained “committed” to ensuring early access to the potential vaccine for Pacific countries and regional partners in Southeast Asia.

Earlier this month he called on nations to share potential vaccines, saying any country that discovered one and did not make it available globally “would be judged terribly by history.”

Read more:

Coronavirus: France to require masks in most workplaces

Israel’s president invites Abu Dhabi Crown Prince to Jerusalem following agreement

Six major events in Oman-Israel relations: Timeline

SHOW MORE
Last Update: Tuesday, 18 August 2020 KSA 15:55 - GMT 12:55
Top